A kidney transplant is the best chance of a good quality of life for someone with End-Stage Renal Failure (ESRF).
Here are 20 questions and answers that describe the kidney transplant process, and what life is like before and after surgery.
A kidney transplant involves surgically placing a healthy kidney from a donor into a patient with End-Stage Renal Failure (ESRF).
A successful procedure eliminates the immediate clinical need for dialysis.
The patient’s native, failing organs are typically left in place unless they cause chronic infection, severe pain, or bleeding.
It is not a complete cure; recipients require lifelong medical surveillance and complex medication regimens.
While a transplant significantly improves quality of life and offers a long-term survival advantage over remaining on the waiting list, it carries typical surgical risks and complications (Abecassis et al., 2008).
Over time, transplanted organs can fail. On average, organs from deceased donors function well for approximately 10 years, whereas kidneys from living donors average 15 years or longer before a replacement or return to dialysis is necessary.
Deceased donors: Individuals who have legally consented to organ donation upon their death, usually following a sudden, catastrophic neurological event.
Living donors: A physically fit partner, relative, or close friend who chooses to donate one of their two healthy kidneys.
Altruistic non-directed donors: Compassionate strangers who voluntarily choose to give a kidney to someone on the public transplant waiting list anonymously (Sharma et al., 2019).
Inclusion on the waiting list is never automatic. A patient must pass a rigorous physical examination to ensure they can survive the stress of surgery and high-dose immunosuppressants.
Approximately 50% of people on dialysis are medically fit and eligible to receive a transplant.
Complications exist; patients must balance the benefits against potential short-term and long-term medical side effects.
The new kidney is positioned low in the lower abdomen (iliac fossa), which is significantly lower than the natural position of human kidneys.
It sits carefully nestled underneath the abdominal wall muscle layer and skin.
The physical outline of the organ can often be felt upon firm pressure just above the pelvic brim (the bony ridge located right above a trouser front pocket).
This lower pelvic placement allows surgeons to easily connect the kidney’s blood vessels to the major iliac vessels and attach the new ureter directly to the urinary bladder.
No, only about half of the individuals undergoing dialysis meet the rigid medical criteria required for a safe transplant surgery.
Primary reasons for medical exclusion include advanced cardiovascular disease, a high risk of lethal post-transplant infections, or active/recent cancer.
These co-existing medical issues lead to an unacceptably high risk of post-operative death or severe sickness when combined with mandatory anti-rejection medication.
Age is a compounding factor; due to natural physical decline and concurrent chronic conditions, few individuals over the age of 70 are completely fit for the procedure (Yemini et al., 2021).
Yes, very much so – utilising a healthy living donor who is a relative, spouse, or friend is a highly effective clinical option.
The candidate must be exceptionally physically fit and undergo thorough psychological screening to ensure they have no personal reservations about donation.
The recipient must also be emotionally ready and comfortable with the reality of putting a loved one through the stress of an elective surgical operation.
The surgical recovery of kidneys from a deceased individual is performed with the highest levels of professional respect and dignity by specialist transplant teams.
For grieving families, consenting to the donation of a loved one’s organs frequently provides profound consolation during a period of deep loss.
The majority of individuals who pass away are ineligible to be organ donors due to advanced age, systemic infection, or history of malignancy.
Most usable organs come from patients who suffer severe strokes or traumatic head injuries, are transferred to an intensive care unit (ICU), and are pronounced dead while attached to a mechanical ventilator.
Deceased donor kidneys are systematically allocated to ensure maximum long-term survival and reduce the risk of immediate kidney transplant failure.
Organs are matched to recipients based heavily on blood group compatibility and human leukocyte antigen (HLA tissue type match).
National kidney transplant networks manage this process centrally, rapidly shipping available kidneys across regions so they are matched with the most (immunologically) compatible recipient.
There is a chronic, worldwide shortage of donor organs relative to the thousands of patients listed on national registries.
In the UK, currently, the average wait time for an organ is approximately 3 years.
The national database functions as a matching pool rather than a chronological queue; patients with a rare blood group or highly sensitised tissue types often face significantly longer wait times.
To safeguard privacy and prevent any unnecessary psychological distress to the grieving family, strict confidentiality protocols are enforced.
The transplant recipient is provided with minimal, non-identifying details regarding the donor, such as their general age bracket.
Recipients generally experience deep gratitude and frequently send a letter of thanks or holiday card, which is delivered anonymously to the donor’s family via a transplant coordinator.
The surgical procedure typically requires about 3 hours of operating time, though patients remain away from their hospital ward for 6 to 7 hours due to anesthesia prep and recovery room monitoring.
Immediately following surgery, patients have multiple intravenous lines in the neck or arms and a urinary catheter in the bladder to track fluid inputs and immediate urine output.
Patients are generally assisted to sit out of bed the day after surgery, and most are safely walking within two to three days.
For a living donor transplant, the typical post-operative hospital stay is brief, averaging 4 to 6 days due to the elective (planned) nature of the surgery (Sharma et al., 2019).
For a deceased donor transplant, patients usually require a stay of 6 to 10 days, as 30% of organs experience temporary delayed graft function (sluggishness) before working fully.
Yes, navigating the transplant journey involves substantial psychological stress, characterised by mixed anxiety and excitement while awaiting the call.
The initial three months post-transplant can be physically and emotionally demanding due to a high frequency of clinic follow-ups (initially three times per week).
Temporary hospital readmissions for medication adjustments, fluid management, or routine organ biopsies occur regularly during this early phase.
In the long term (3 years after the transplant), if transplant function is stable, the organ stabilises, clinical follow-ups decrease significantly, eventually requiring hospital visits (or telephone appointments) only once every 3 months.
Transplantation carries standard perioperative risks, including a small, inherent risk of mortality during or shortly after the surgical window.
Primary complications include localised issues with the kidney, such as acute rejection, hepatic/renal artery blood clots, or urine drainage blockages.
Immunosuppressive drugs increase susceptibility to opportunistic infections, alongside metabolic changes like high blood pressure and elevated cholesterol levels.
There is an increased long-term risk of malignancy; localised skin cancers are the most common, while lymphoma (a blood cancer) develops in roughly 2% of transplant patients.
Rejection occurs when the host immune system recognises the donor organ as foreign tissue and attacks it like an infectious germ.
Roughly one-third of patients experience an episode of acute rejection within the first few weeks after surgery.
This is routinely caught early via subtle changes in blood test results (such as a rise in serum creatinine levels) and is successfully managed with high-dose intravenous steroids.
The overall risk of completely losing a newly transplanted kidney to severe, unmanageable acute rejection in the initial weeks is low, at roughly 5%.
Recipients must take daily medications for the lifetime of the organ; stopping these medications causes immediate immune-mediated rejection and graft failure.
Anti-rejection (immunosuppressive) drugs: Most centres use a ‘triple therapy’ protocol consisting of tacrolimus, mycophenolate, and prednisolone.
Prophylactic medications: Temporary therapies designed to prevent viral or bacterial infections caused by a suppressed immune system, such as valganciclovir (for CMV) and septrin (for PCP pneumonia).
Supportive therapies: Long-term prescription medications to tightly control secondary metabolic side effects like chronic high blood pressure or elevated cholesterol.
It is highly common; up to 30% of recipients develop New-Onset Diabetes After Transplantation (NODAT) or Post-Transplant Diabetes Mellitus (PTDM).
This metabolic shift occurs primarily as a side effect of mandatory immunosuppressants, specifically corticosteroids (prednisolone) and calcineurin inhibitors (CNIs; tacrolimus and ciclosporin).
For individuals who presented with pre-existing diabetes prior to surgery, blood glucose levels can become significantly more volatile and harder to regulate post-operatively.
Sexual function and overall libido typically improve significantly compared to time spent on dialysis as the body successfully clears uraemic toxins.
Fertility levels return toward normal ranges, making it much easier for female recipients to conceive and carry a child—a rare milestone while on active dialysis (Abecassis et al., 2008).
Women are strongly counselled to avoid pregnancy during the first year post-surgery to allow renal function to fully stabilize and to safely transition away from teratogenic (birth-defect-causing) anti-rejection drugs like mycophenolate.
Yes, very much so – the primary objective of transplantation is to restore patients to an active, independent lifestyle, though the primary diseases that caused kidney failure (like diabetes) require ongoing management.
Clinical guidelines recommend planning for 3 months off work post-surgery to ensure full recovery of the abdominal wall incision and stabilisation of medication levels.
Following this recovery window, the vast majority of patients successfully return to full-time employment, unrestricted travel, and regular exercise.
Yes, if a transplanted kidney stops functioning, patients can safely return to dialysis and seek evaluation for a subsequent transplant.
The patient must undergo another comprehensive medical screening to ensure their cardiovascular system and overall physical health can safely withstand another surgery.
Finding a well-matched secondary organ can be highly challenging, as the immune system often possesses elevated antibodies from the first organ, requiring a more precise tissue match or specialised desensitisation treatments.
United States Sources
Abecassis, M., Bartlett, S. T., Collins, A. J., Davis, C. L., Delmonico, F. L., Friedewald, J. J., Hays, R., Howard, A., Jones, E., Leichtman, A. B., Merion, R. M., Metzger, A. B., Pradel, F., Schweitzer, E. J., Velez, R. L., & Gaston, R. S. (2008). Kidney transplantation as primary therapy for end-stage renal disease. Clinical Journal of the American Society of Nephrology, 3(2), 471–480. https://doi.org/10.2215/cjn.05021107
Cited by: 857
Yemini, R., Rahamimov, R., Ghinea, R., & Mor, E. (2021). Long-term results of kidney transplantation in the elderly: Comparison between different donor settings. Journal of Clinical Medicine, 10(22), 5308. https://doi.org/10.3390/jcm10225308
Cited by: 23
United Kingdom Sources
Sharma, V., Summers, A., Picton, M., Ainsworth, J., Van Dellen, D., Jones, R., & Augustine, T. (2019). Living donor kidney transplantation: often a missed opportunity. British Journal of General Practice, 69(686), 428–429. https://doi.org/10.3390/bjgp19x705173
Cited by: 4
Pruthi, R., Casula, A., & MacPhee, I. (2015). UK Renal Registry 17th Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2013: National and Centre-specific Analyses. Nephron, 129(Suppl. 1), 57–86. https://doi.org/10.1159/000370273
Should I see a doctor about a crick neck? No, not usually. In this article we will describe when you should see a doctor about a crick neck. What is a crick neck? Crick in the neck is an imprecise ter...
Indapamide – a water tablet for high blood pressure Indapamide is a water tablet (diuretic) that works on the kidneys for high blood pressure. What is Indapamide? Indapamide is a type of medicin...
Eczema (Atopic Dermatitis): 5 Common Signs & When to See a Doctor Eczema is more than just dry skin; it is a chronic inflammatory condition that affects millions. In the UK alone, it impacts rough...
5 Ways to Keep Your Hair Healthy Maintaining vibrant, healthy hair is a multifaceted endeavor that involves both protecting the external protein structure of the hair shaft and optimizing the biologic...
